Otto Kanzler has more than 30 years experience in process- and business development in the biotech industry. As of 2007 he is serving as Management Consultant for production and technology-development for biotech- and pharmaceutical industry, specified for strategic and economic issues. Between 1993 and 2007 he was head of biopharmaceutical coordination and planning at Boehringer Ingelheim Austria, Vienna, responsible for the economic issues of the industrial biopharmaceutical business. Prior to this he was head of process development for biopharmaceutical processes at Boehringer Ingelheim Austria (1981-1993). In addition, Otto Kanzler is CEO and co-founder of several Austrian-based Biotech-Companies.
Fredrik DeBong is a successful serial entrepreneur. In 1984 he was diagnosed with type 1 diabetes, which led him to be one of the cofounders of mySugr, with the goal of making diabetes therapy more fun and engaging. The diabetes management system is, among other interesting tidbits, one of the first apps in the AppStore which is a standalone „medical device“, carries the CE mark and has been developed in accordance to European and US medical device guidelines and laws.
Michael Hammerschmid studied Food- and Biotechnology at the University of Natural Resources and Life Sciences, Vienna, and has more than 17 years professional experience in the biopharmaceutical industry. He has held different leading positions, mainly at Boehringer Ingelheim RCV, Vienna (1994-2001, 2003-2013). In this period M. Hammerschmid developed strong knowledge and management skills in a constantly changing organization. He headed different functional units such as process science, production, as well as quality control and support units, as well as managing international contract manufacturing projects. The experience of working as COO in a start up company in the field of medical diagnostic supplemented his experience for the specific needs for the initial stage of an organisation (VBC-Genomics, 2002-2003). In addition, M. Hammerschmid is CEO and co-founder of Transform Science Management GmbH (www.transform-science.com)
Lo Gunnar Otto Gorton’s current affiliation is Department of Analytical Chemistry / Biochemistry and Structural Biology, University of Lund, Sweden.
He holds a Bachelor’s degree of genetics, botany, microbiology and a Master’s degree of chemistry from Lund University. After working for one year as technician at the wastewater treatment plant in Malmö he started and graduated as PhD with a thesis entitled: A Study of Modified Electrodes and Enzyme Reactors. After various positions at Lund University he became Associate Professor (docent) in analytical chemistry in 1986 and finally in 1997 Lo Gorton became the chair professor in analytical chemistry. Except for bioelectrochemistry his research interests cover immobilised enzymes, flow injection analysis, liquid chromatography, mass spectrometry, polysaccharide hydrolysing enzymes and their use for analysis and characterisation of derivatised cellulose, hemicellulose and starch.
He holds a diploma degree in mechanical engineering from technical university of Karlsruhe (KIT), Germany. After that he worked in software for automation technology, followed by 20 years of experience at Boehringer Mannheim/Roche Diagnostic in fields of CAD Implementation and construction, project leader mechanics, strategic purchasing, project leader PoC-platform, technology development “Lab-on- Disc”. Since 2010 Manfred Augstein is CEO of velixX GmbH. www.velixX.com
He obtained his diploma degree in chemistry from the University in Karlsruhe, Germany (1982) and his PhD from the Technical University of Munich (1986). After finishing his habilitation thesis at the Technical University of Munich in 1993, he was appointed to be a professor for Analytical Chemistry at the Ruhr-Universität Bochum in 1996. His research interest addresses the development of reagentless amperometric biosensors, micro-electrochemistry, miniaturization of biosensors, scanning electrochemical microscopy, combinatorial microelectrochemistry, electrochemical robotics, miniaturised sensors for local measurements at biological cells, biofuel cells, localized corrosion, microelectrochemical investigations of fuelcell catalyst and battery materials, new materials for electrocatalysis and photoelectrocatalysis as well as the in-depth understanding of electrified interfaces.